Orser Capital Management LLC Has $2.07 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Orser Capital Management LLC boosted its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 4.7% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,829 shares of the company’s stock after acquiring an additional 1,213 shares during the quarter. Colgate-Palmolive accounts for about 2.1% of Orser Capital Management LLC’s portfolio, making the stock its 15th largest position. Orser Capital Management LLC’s holdings in Colgate-Palmolive were worth $2,067,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in CL. Dimensional Fund Advisors LP grew its holdings in Colgate-Palmolive by 4.0% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,444,508 shares of the company’s stock worth $185,376,000 after acquiring an additional 94,837 shares during the last quarter. Covestor Ltd grew its holdings in Colgate-Palmolive by 71.9% during the 1st quarter. Covestor Ltd now owns 2,451 shares of the company’s stock worth $186,000 after acquiring an additional 1,025 shares during the last quarter. Mackenzie Financial Corp grew its holdings in Colgate-Palmolive by 8.5% during the 1st quarter. Mackenzie Financial Corp now owns 1,882,813 shares of the company’s stock worth $142,774,000 after acquiring an additional 146,936 shares during the last quarter. First Western Trust Bank bought a new stake in Colgate-Palmolive during the 1st quarter worth approximately $569,000. Finally, Wsfs Capital Management LLC bought a new stake in Colgate-Palmolive during the 1st quarter worth approximately $288,000. 78.36% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Deutsche Bank Aktiengesellschaft boosted their target price on shares of Colgate-Palmolive from $88.00 to $91.00 and gave the stock a “buy” rating in a report on Monday, July 31st. Barclays upped their price objective on shares of Colgate-Palmolive from $77.00 to $81.00 and gave the company an “equal weight” rating in a research note on Tuesday, August 1st. StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Monday, September 11th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $83.00 price objective on shares of Colgate-Palmolive in a research note on Monday, July 31st. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $85.33.

Get Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.4 %

Shares of NYSE CL opened at $73.17 on Friday. The firm has a market cap of $60.49 billion, a PE ratio of 40.65, a P/E/G ratio of 3.10 and a beta of 0.50. Colgate-Palmolive has a 12-month low of $67.84 and a 12-month high of $82.09. The company’s fifty day simple moving average is $75.06 and its 200 day simple moving average is $75.83. The company has a quick ratio of 0.73, a current ratio of 1.17 and a debt-to-equity ratio of 28.43.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, July 28th. The company reported $0.77 earnings per share for the quarter, topping the consensus estimate of $0.75 by $0.02. Colgate-Palmolive had a net margin of 8.02% and a return on equity of 386.76%. The firm had revenue of $4.82 billion for the quarter, compared to the consensus estimate of $4.70 billion. During the same quarter in the prior year, the company posted $0.72 earnings per share. The business’s revenue was up 7.5% on a year-over-year basis. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.17 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, November 15th. Shareholders of record on Monday, October 23rd will be issued a dividend of $0.48 per share. The ex-dividend date is Friday, October 20th. This represents a $1.92 annualized dividend and a yield of 2.62%. Colgate-Palmolive’s payout ratio is 106.67%.

Insiders Place Their Bets

In other Colgate-Palmolive news, VP Gregory Malcolm sold 10,493 shares of the company’s stock in a transaction on Thursday, August 31st. The shares were sold at an average price of $73.90, for a total transaction of $775,432.70. Following the transaction, the vice president now owns 7,852 shares in the company, valued at $580,262.80. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, CEO Noel R. Wallace sold 48,627 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $73.37, for a total value of $3,567,762.99. Following the completion of the sale, the chief executive officer now owns 246,969 shares in the company, valued at $18,120,115.53. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Gregory Malcolm sold 10,493 shares of the stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $73.90, for a total transaction of $775,432.70. Following the completion of the sale, the vice president now owns 7,852 shares of the company’s stock, valued at approximately $580,262.80. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 105,501 shares of company stock worth $7,838,332. Insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.